| Medicinal product name | Leucovorin-Teva 10 mg/ml solution for injection |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Solution for injection | ||||||
| Strength | 10 mg/ml | ||||||
| Information from the MAH on shortages |
planned withdraw date: Jun 24, 2024 |
||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) | ||||||
| Package leaflet |  27-02-2024
|
||||||
| Summary of product characteristics | 27-02-2024
|
||||||
| ATC code | V03AF03 – All other therapeutic products | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (5)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
|
Not available (according to the information provided by wholesalers) predicted availability date: not notified |
currently no information on availability from any wholesaler |
N1 (50 mg/5 ml) |
Glass vial | 99-0863-01 |
Labelling text Feb 27, 2024 Labelling text Feb 27, 2024 |
|
|
Is available (according to the information provided by wholesalers) (7289 containers) planned withdraw date: Jun 24, 2024 |
Tamro |
N1 (100 mg/10 ml) |
Glass vial | € 24.00 | 99-0863-02 |
Labelling text Feb 27, 2024 Labelling text Feb 27, 2024 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (200 mg/20 ml) |
Glass vial | 99-0863-03 |
Labelling text Feb 27, 2024 Labelling text Feb 27, 2024 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (300 mg/30 ml) |
Glass vial | 99-0863-04 |
Labelling text Feb 27, 2024 Labelling text Feb 27, 2024 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (500 mg/50 ml) |
Glass vial | 99-0863-05 |
Labelling text Feb 27, 2024 Labelling text Feb 27, 2024 |
Registration information
| Marketing authorisation No. | 99-0863 |
|---|---|
| Date of authorisation | Nov 24, 1999 |
| Marketing authorisation holder, country | Teva Pharma B.V., Netherlands |
